As a result, non-discriminative inhibition of EGFR signaling in a whole organism leads to skin rashes and cardiac toxicity.8 Similarly, activation of TrkA signaling via intracerebral infusion of NGF emerged as a potential therapy for Alzheimer's disease. The gene discussed is NTRK1; the disease is early-onset autosomal dominant Alzheimer disease.